High rates of death and loss to follow-up by 12 months of rifampicin resistant TB treatment in South Africa.

At this outpatient DR-TB treatment site, there was a high rate of attrition halfway through the standard treatment course at 12 months of 31%. High rates of attrition by 12 months on treatment may continue during the second-half of therapy.